Inhibition of PI3K suppresses propagation of drug-tolerant cancer cell subpopulations enriched by 5-fluorouracil

被引:10
|
作者
Ishida, Kaoru [1 ]
Ito, Chie [1 ]
Ohmori, Yukimi [1 ]
Kume, Kohei [1 ,2 ]
Sato, Kei A. [1 ]
Koizumi, Yuka [1 ]
Konta, Akari [1 ]
Iwaya, Takeshi [1 ]
Nukatsuka, Mamoru [3 ]
Kobunai, Takashi [3 ]
Takechi, Teiji [3 ]
Nishizuka, Satoshi S. [1 ,2 ,4 ]
机构
[1] Iwate Med Univ, Dept Surg, Sch Med, Mol Therapeut Lab, Morioka, Iwate 0208505, Japan
[2] Iwate Med Univ, Inst Biomed Sci, Div Biomed Res & Dev, Morioka, Iwate 0208505, Japan
[3] Taiho Pharmaceut Co Ltd, Translat Res Lab, Tokushima, Tokushima 7710194, Japan
[4] George Mason Univ, Inst Adv Biomed Res, Ctr Appl Prote & Mol Med, Manassas, VA 20110 USA
来源
SCIENTIFIC REPORTS | 2017年 / 7卷
关键词
GASTRIC-CANCER; ADAPTIVE RESISTANCE; PIK3CA MUTATION; TUMOR-CELLS; POTENT; GDC-0941; IDENTIFICATION; CHEMOTHERAPY; SURGERY;
D O I
10.1038/s41598-017-02548-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Drug-tolerant cancer cell subpopulations are responsible for relapse after chemotherapy. By continuously exposing the gastric cancer cell line MKN45 to 5-FU for > 100 passages, we established a 5-fluorouracil (5-FU)-tolerant line, MKN45/5FU. Orthotopic xenografts of MKN45/5FU cells in the stomach of nude mice revealed that these cells had a high potential to metastasize to sites such as the liver. Levels of phosphorylated phosphatidylinositide 3-kinase (PI3K) increased both in 5-FU-tolerant subpopulations according to the 5-FU dose, and in gastric submucosal orthotopic xenografts of MKN45/5FU cells. Sequential administration of 5-FU and a PI3K inhibitor, GDC-0941, targeted the downstream ribosomal S6 kinase phosphorylation to significantly suppress 5-FU-tolerant subpopulations and tumor propagation of orthotopic MKN45/5FU xenografts. These results suggest that administration of 5-FU followed by GDC-0941 may suppress disease relapse after 5-FU-based gastric cancer chemotherapy.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Inhibition of PI3K/Akt/mTOR Signaling Pathway Suppresses 5-Fluorouracil Resistance in Gastric Cancer
    Xing, Zhiwei
    Gao, Yanan
    Shi, Yaxuan
    Gao, Ziyu
    Liu, Caixia
    MOLECULAR BIOTECHNOLOGY, 2024, 66 (12) : 3640 - 3654
  • [2] Effects of Artemisinin Combined with 5-Fluorouracil on Colon Cancer Cell Proliferation, Migration, and Drug Sensitivity via PI3K/AKT Signaling
    Wang, Yongqi
    Chen, Yong
    Liu, Lijie
    He, Donglei
    Li, He
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2020, 10 (11) : 1600 - 1604
  • [3] Synergistic effect of kaempferol and 5-fluorouracil on the growth of colorectal cancer cells by regulating the PI3K/Akt signaling pathway
    Li, Qiongyu
    Wei, Lihui
    Lin, Shan
    Chen, Youqin
    Lin, Jiumao
    Peng, Jun
    MOLECULAR MEDICINE REPORTS, 2019, 20 (01) : 728 - 734
  • [4] α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15
    Kume, Kohei
    Ikeda, Miyuki
    Miura, Sawako
    Ito, Kohei
    Sato, Kei A.
    Ohmori, Yukimi
    Endo, Fumitaka
    Katagiri, Hirokatsu
    Ishida, Kaoru
    Ito, Chie
    Iwaya, Takeshi
    Nishizuka, Satoshi S.
    SCIENTIFIC REPORTS, 2016, 6
  • [5] Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway
    Shan, Hui
    Zhang, Xin
    Mi, Yalu
    Jia, Jihui
    Wang, Bo
    Yang, Qing
    PHARMACEUTICALS, 2022, 15 (12)
  • [6] Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells
    Zhu, Youlong
    Yu, Jiwei
    Wang, Shoulian
    Lu, Ruiqi
    Wu, Jugang
    Jiang, Bojian
    ONCOLOGY REPORTS, 2014, 32 (06) : 2437 - 2444
  • [7] The PI3K Pathway As Drug Target in Human Cancer
    Courtney, Kevin D.
    Corcoran, Ryan B.
    Engelman, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 1075 - 1083
  • [8] Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade
    Zhang, Binhao
    Leng, Chao
    Wu, Chao
    Zhang, Zhanguo
    Dou, Lei
    Luo, Xin
    Zhang, Bixiang
    Chen, Xiaoping
    ONCOLOGY REPORTS, 2016, 35 (03) : 1807 - 1815
  • [9] PI3K Inhibition for Squamous Cell Head and Neck Carcinoma
    Desilets, Antoine
    Soulieres, Denis
    CANCER JOURNAL, 2022, 28 (05) : 369 - 376
  • [10] PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway
    Xing, Xiaofang
    Zhang, Lianhai
    Wen, Xianzi
    Wang, Xiaohong
    Cheng, Xiaojing
    Du, Hong
    Hu, Ying
    Li, Lin
    Dong, Bin
    Li, Ziyu
    Ji, Jiafu
    ANTI-CANCER DRUGS, 2014, 25 (10) : 1129 - 1140